The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Spalax

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Spalax

 

High impact information on Spalax

  • Adaptive evolution of heparanase in hypoxia-tolerant Spalax: gene cloning and identification of a unique splice variant [2].
  • After 24 h of 10% O(2), Spalax Epo reaches its maximal expression, remarkably 6-fold higher than the maximum in Rattus; (ii) the HIF-1 alpha level in normoxia is 2-fold higher in Spalax than in Rattus [3].
  • Evolution of p53 in hypoxia-stressed Spalax mimics human tumor mutation [4].
  • Comparing Spalax with human and mouse p53 revealed an arginine (R) to lysine (K) substitution in Spalax (Arg-174 in human) in the DNA-binding domain, identical to known tumor associated mutations [4].
  • Spalax VEGF muscular infiltration resulted in a faster and more complete restoration of blood flow [5].
 

Chemical compound and disease context of Spalax

  • Furthermore, as opposed to Rattus, the mRNA levels of HIF-1alpha, HuR, VEGF, as well as that of LDH-A, the enzyme that catalyzes the production of lactate, an accepted marker of anaerobic metabolism, are not increased in Spalax after hypoxia [6].
 

Biological context of Spalax

 

Anatomical context of Spalax

 

Associations of Spalax with chemical compounds

  • We suggest that this reduction in transcriptional activity may be attributed to the Spalax Clock glutamine-rich domain, which is unique in its amino acid composition compared with other studied mammalian species [8].
  • In this paper we explore whether Spalax is a dichromat and has the potential to use colour discrimination for photoentrainment [13].
  • Only one difference with the previously determined sequence of the superspecies Spalax ehrenbergi was detected; the proline residue at position 42 has been replaced by alanine [14].
  • Also in contrast to the rodent pigments, the Spalax pigment exhibits anion-dependent spectral properties, displaying a 12 nm blue-shift upon substitution of chloride ions by nitrate ions [15].
 

Gene context of Spalax

  • The Spalax CRY1 protein is significantly closer to the human homolog than to the mice one, in contrast to the evolutionary expectations [10].
  • The sequence of the cDNA of alpha-B-Crystallin in the eye and in the heart of Spalax is identical [16].
  • In order to extend knowledge of rodent GHs we have cloned and characterised part of the GH gene of the Eurasian mole rat (Spalax ehrenbergi) using genomic DNA and a PCR technique [17].
  • These data support the hypothesis that the LWS opsin of Spalax acts as a functional photopigment and that it is not a 'residue' of the pre-subterranean visual system [18].
  • As was already shown for other circadian genes, despite being blind and living in darkness, the Cry genes of Spalax behave in a similar, though not identical, pattern as in sighted animals [10].

References

  1. Ontogenetic expression of erythropoietin and hypoxia-inducible factor-1 alpha genes in subterranean blind mole rats. Shams, I., Nevo, E., Avivi, A. FASEB J. (2005) [Pubmed]
  2. Adaptive evolution of heparanase in hypoxia-tolerant Spalax: gene cloning and identification of a unique splice variant. Nasser, N.J., Nevo, E., Shafat, I., Ilan, N., Vlodavsky, I., Avivi, A. Proc. Natl. Acad. Sci. U.S.A. (2005) [Pubmed]
  3. Hypoxic stress tolerance of the blind subterranean mole rat: expression of erythropoietin and hypoxia-inducible factor 1 alpha. Shams, I., Avivi, A., Nevo, E. Proc. Natl. Acad. Sci. U.S.A. (2004) [Pubmed]
  4. Evolution of p53 in hypoxia-stressed Spalax mimics human tumor mutation. Ashur-Fabian, O., Avivi, A., Trakhtenbrot, L., Adamsky, K., Cohen, M., Kajakaro, G., Joel, A., Amariglio, N., Nevo, E., Rechavi, G. Proc. Natl. Acad. Sci. U.S.A. (2004) [Pubmed]
  5. Restoration of blood flow by using continuous perimuscular infiltration of plasmid DNA encoding subterranean mole rat Spalax ehrenbergi VEGF. Roguin, A., Avivi, A., Nitecki, S., Rubinstein, I., Levy, N.S., Abassi, Z.A., Resnick, M.B., Lache, O., Melamed-Frank, M., Joel, A., Hoffman, A., Nevo, E., Levy, A.P. Proc. Natl. Acad. Sci. U.S.A. (2003) [Pubmed]
  6. Increased blood vessel density provides the mole rat physiological tolerance to its hypoxic subterranean habitat. Avivi, A., Shams, I., Joel, A., Lache, O., Levy, A.P., Nevo, E. FASEB J. (2005) [Pubmed]
  7. Major histocompatibility complex gene organization in the mole rat Spalax ehrenbergi: evidence for transfer of function between class II genes. Nizetić, D., Figueroa, F., Dembić, Z., Nevo, E., Klein, J. Proc. Natl. Acad. Sci. U.S.A. (1987) [Pubmed]
  8. Biological clock in total darkness: the Clock/MOP3 circadian system of the blind subterranean mole rat. Avivi, A., Albrecht, U., Oster, H., Joel, A., Beiles, A., Nevo, E. Proc. Natl. Acad. Sci. U.S.A. (2001) [Pubmed]
  9. Molecular evolution of cytochrome b of subterranean mole rats, Spalax ehrenbergi superspecies, in Israel. Nevo, E., Beiles, A., Spradling, T. J. Mol. Evol. (1999) [Pubmed]
  10. Circadian genes in a blind subterranean mammal III: molecular cloning and circadian regulation of cryptochrome genes in the blind subterranean mole rat, Spalax ehrenbergi superspecies. Avivi, A., Oster, H., Joel, A., Beiles, A., Albrecht, U., Nevo, E. J. Biol. Rhythms (2004) [Pubmed]
  11. Auditory pathway and auditory activation of primary visual targets in the blind mole rat (Spalax ehrenbergi): I. 2-deoxyglucose study of subcortical centers. Bronchti, G., Heil, P., Scheich, H., Wollberg, Z. J. Comp. Neurol. (1989) [Pubmed]
  12. The circadian photopigment melanopsin is expressed in the blind subterranean mole rat, Spalax. Hannibal, J., Hindersson, P., Nevo, E., Fahrenkrug, J. Neuroreport (2002) [Pubmed]
  13. Adaptive loss of ultraviolet-sensitive/violet-sensitive (UVS/VS) cone opsin in the blind mole rat (Spalax ehrenbergi). David-Gray, Z.K., Bellingham, J., Munoz, M., Avivi, A., Nevo, E., Foster, R.G. Eur. J. Neurosci. (2002) [Pubmed]
  14. The primary structure of pancreatic ribonuclease from mole rat superspecies Spalax leucodon. Zhao, W., Beintema, J.J., Hofsteenge, J., Nevo, E. Mol. Phylogenet. Evol. (1993) [Pubmed]
  15. A green cone-like pigment in the 'blind' mole-rat Spalax ehrenbergi: functional expression and photochemical characterization. Janssen, J.W., David-Gray, Z.K., Bovee-Geurts, P.H., Nevo, E., Foster, R.G., DeGrip, W.J. Photochem. Photobiol. Sci. (2003) [Pubmed]
  16. The lens protein alpha-B-crystallin of the blind subterranean mole-rat: high homology with sighted mammals. Avivi, A., Joel, A., Nevo, E. Gene (2001) [Pubmed]
  17. Cloning and characterisation of the gene encoding mole rat (Spalax ehrenbergi) growth hormone. Lioupis, A., Nevo, E., Wallis, M. J. Mol. Endocrinol. (1999) [Pubmed]
  18. Spectral tuning of a circadian photopigment in a subterranean 'blind' mammal (Spalax ehrenbergi). David-Gray, Z.K., Cooper, H.M., Janssen, J.W., Nevo, E., Foster, R.G. FEBS Lett. (1999) [Pubmed]
 
WikiGenes - Universities